CytoSorbents Achieves Record Total Revenue and CytoSorb Sales in the Second Quarter 2018
Go back to CytoSorbents Achieves Record Total Revenue and CytoSorb Sales in the Second Quarter 2018| Cytosorbents Corporation (NASDAQ: CTSO) | Delayed: 5.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.75 | 52 Week High | $7.48 | |||
| Open | $5.75 | 52 Week Low | $3.11 | |||
| Day High | $5.75 | P/E | N/A | |||
| Day Low | $5.75 | EPS | $-0.03 | |||
| Volume | 482 | |||||
